Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Neurocognitive Disorder With Aggressive Behavior”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)Ended earlyNCT01766336
What this trial is testing

A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 296
Testing effectiveness (Phase 2)UnknownNCT04436081
What this trial is testing

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementiaMajor Neurocognitive Disorder With Aggressive Behavior
Eastern Virginia Medical School 40
Post-approval studies (Phase 4)Study completedNCT00401167
What this trial is testing

Memantine for Agitation and Aggression in Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sunnybrook Health Sciences Centre 31
Testing effectiveness (Phase 2)Study completedNCT01735630
What this trial is testing

Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 350

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation